{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T01:11:20Z","timestamp":1755997880927},"reference-count":36,"publisher":"Impact Journals, LLC","issue":"19","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2023,10,15]]},"DOI":"10.18632\/aging.205061","type":"journal-article","created":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T15:06:01Z","timestamp":1696259161000},"page":"10117-10132","source":"Crossref","is-referenced-by-count":6,"title":["Causal association between placental growth factor and coronary heart disease: a Mendelian randomization study"],"prefix":"10.18632","volume":"15","author":[{"given":"Bo","family":"Zuo","sequence":"first","affiliation":[{"name":"Department of Cardiology, Cardiovascular Centre, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sha","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Peking University International Hospital, Beijing 102206, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoting","family":"Zhong","sequence":"additional","affiliation":[{"name":"Department of Neurology, Peking University International Hospital, Beijing 102206, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haoyang","family":"Bu","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Hospital of Handan, Handan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Cardiovascular Centre, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2023,10,2]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1016\/S0140-6736(18)32335-3","article-title":"Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.","volume":"39","author":"GBD 2017 DALYs and HALE Collaborators","year":"2018","journal-title":"Lancet"},{"key":"2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/978-3-642-59953-8_2","article-title":"Structure, expression and receptor-binding properties of placenta growth factor (PlGF).","volume":"23","author":"DiPalma","year":"1999","journal-title":"Curr Top Microbiol Immunol"},{"key":"3","doi-asserted-by":"publisher","first-page":"a011056","DOI":"10.1101\/cshperspect.a011056","article-title":"PlGF: a multitasking cytokine with disease-restricted activity.","volume":"2","author":"Carmeliet","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"4","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3858\/emm.2012.44.1.023","article-title":"Role of placenta growth factor in cancer and inflammation.","volume":"4","author":"Kim","year":"2012","journal-title":"Exp Mol Med"},{"key":"5","first-page":"25646","article-title":"Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1\/KDR.","volume":"26","author":"Ferrara","year":"1994","journal-title":"J Biol Chem"},{"key":"6","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.cytogfr.2017.12.001","article-title":"Fractalkine and placental growth factor: A duet of inflammation and angiogenesis in cardiovascular disorders.","volume":"3","author":"Szukiewicz","year":"2018","journal-title":"Cytokine Growth Factor Rev"},{"key":"7","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1016\/j.jacc.2005.11.064","article-title":"Cardiac expression of placental growth factor predicts the improvement of chronic phase left ventricular function in patients with acute myocardial infarction.","volume":"4","author":"Takaoka","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"8","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1161\/CIRCULATIONAHA.118.036632","article-title":"Placental Growth Factor as an Indicator of Maternal Cardiovascular Risk After Pregnancy.","volume":"13","author":"Gandley","year":"2019","journal-title":"Circulation"},{"key":"9","doi-asserted-by":"publisher","first-page":"785","DOI":"10.2217\/bmm-2018-0492","article-title":"Placenta growth factor and sFlt-1 as biomarkers in ischemic heart disease and heart failure: a review.","volume":"1","author":"Torry","year":"2019","journal-title":"Biomark Med"},{"key":"10","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1097\/SMJ.0b013e3181eda4ef","article-title":"Placental growth factor as short-term predicting biomarker in acute coronary syndrome patients with non-ST elevation myocardial infarction.","volume":"10","author":"Majki\u0107-Singh","year":"2010","journal-title":"South Med J"},{"key":"11","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1373\/clinchem.2006.080192","article-title":"Multiple biomarker use for detection of adverse events in patients presenting with symptoms suggestive of acute coronary syndrome.","volume":"5","author":"Murakami","year":"2007","journal-title":"Clin Chem"},{"key":"12","doi-asserted-by":"publisher","first-page":"eabc8587","DOI":"10.1126\/scitranslmed.abc8587","article-title":"Evidence for a protective role of placental growth factor in cardiovascular disease.","volume":"1","author":"Nilsson","year":"2020","journal-title":"Sci Transl Med"},{"key":"13","doi-asserted-by":"publisher","first-page":"k601","DOI":"10.1136\/bmj.k601","article-title":"Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians.","volume":"36","author":"Davey Smith","year":"2018","journal-title":"BMJ"},{"key":"14","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1093\/aje\/kwt084","article-title":"Efficient design for Mendelian randomization studies: subsample and 2-sample instrumental variable estimators.","volume":"17","author":"Burgess","year":"2013","journal-title":"Am J Epidemiol"},{"key":"15","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1161\/ATVBAHA.108.171066","article-title":"Potential role for plasma placental growth factor in predicting coronary heart disease risk in women.","volume":"2","author":"Rimm","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"16","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1080\/00365510500235970","article-title":"Elevated placental growth factor (PlGF) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy.","volume":"24","author":"Parving","year":"2005","journal-title":"Scand J Clin Lab Invest Suppl"},{"key":"17","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.jacc.2005.08.063","article-title":"Elevated placental growth factor levels are associated with adverse outcomes at four-year follow-up in patients with acute coronary syndromes.","volume":"4","author":"Boersma","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"18","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s11239-012-0704-z","article-title":"Elevated concentration of placental growth factor (PlGF) and long term risk in patients with acute coronary syndrome in the PROVE IT-TIMI 22 trial.","volume":"3","author":"Morrow","year":"2012","journal-title":"J Thromb Thrombolysis"},{"key":"19","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1001\/jama.291.4.435","article-title":"Prognostic value of placental growth factor in patients with acute chest pain.","volume":"29","author":"Zeiher","year":"2004","journal-title":"JAMA"},{"key":"20","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1093\/cvr\/cvp062","article-title":"Cardioprotective growth factors.","volume":"8","author":"Yellon","year":"2009","journal-title":"Cardiovasc Res"},{"key":"21","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1016\/j.freeradbiomed.2007.02.011","article-title":"VEGFR1 (Flt-1+\/-) gene knockout leads to the disruption of VEGF-mediated signaling through the nitric oxide\/heme oxygenase pathway in ischemic preconditioned myocardium.","volume":"4","author":"Maulik","year":"2007","journal-title":"Free Radic Biol Med"},{"key":"22","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.yjmcc.2004.11.033","article-title":"Ischemic preconditioning-mediated cardioprotection is disrupted in heterozygous Flt-1 (VEGFR-1) knockout mice.","volume":"3","author":"Maulik","year":"2005","journal-title":"J Mol Cell Cardiol"},{"key":"23","doi-asserted-by":"publisher","first-page":"e0202772","DOI":"10.1371\/journal.pone.0202772","article-title":"Treatment with placental growth factor attenuates myocardial ischemia\/reperfusion injury.","volume":"1","author":"Li","year":"2018","journal-title":"PLoS One"},{"key":"24","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1111\/j.1540-8191.2006.00296.x","article-title":"Placental growth factor provides a novel local angiogenic therapy for ischemic cardiomyopathy.","volume":"2","author":"Woo","year":"2006","journal-title":"J Card Surg"},{"key":"25","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1038\/nm731","article-title":"Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1.","volume":"8","author":"Bohlen","year":"2002","journal-title":"Nat Med"},{"key":"26","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1253\/circj.cj-08-1067","article-title":"Treatment with recombinant placental growth factor (PlGF) enhances both angiogenesis and arteriogenesis and improves survival after myocardial infarction.","volume":"7","author":"Kawata","year":"2009","journal-title":"Circ J"},{"key":"27","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1159\/000438544","article-title":"SIRT1 and FOXO Mediate Contractile Differentiation of Vascular Smooth Muscle Cells under Cyclic Stretch.","volume":"3","author":"Jiang","year":"2015","journal-title":"Cell Physiol Biochem"},{"key":"28","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/path.2408","article-title":"Beneficial effects of prolonged systemic administration of PlGF on late outcome of post-ischaemic myocardial performance.","volume":"21","author":"Carmeliet","year":"2008","journal-title":"J Pathol"},{"key":"29","doi-asserted-by":"publisher","first-page":"2828","DOI":"10.1161\/CIRCULATIONAHA.104.495887","article-title":"Placental growth factor promotes atherosclerotic intimal thickening and macrophage accumulation.","volume":"11","author":"Zachary","year":"2005","journal-title":"Circulation"},{"key":"30","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1093\/cvr\/cvp380","article-title":"Short-term delivery of anti-PlGF antibody delays progression of atherosclerotic plaques to vulnerable lesions.","volume":"8","author":"Carmeliet","year":"2010","journal-title":"Cardiovasc Res"},{"key":"31","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1007\/s12265-017-9742-4","article-title":"Sustained Placental Growth Factor-2 Treatment Does Not Aggravate Advanced Atherosclerosis in Ischemic Cardiomyopathy.","volume":"1","author":"Janssens","year":"2017","journal-title":"J Cardiovasc Transl Res"},{"key":"32","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.cell.2007.08.038","article-title":"Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels.","volume":"13","author":"Plaisance","year":"2007","journal-title":"Cell"},{"key":"33","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1038\/s42255-020-00287-2","article-title":"Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.","volume":"2","author":"Boutin","year":"2020","journal-title":"Nat Metab"},{"key":"34","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/ng.3396","article-title":"A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease.","volume":"4","author":"Dehghan","year":"2015","journal-title":"Nat Genet"},{"key":"35","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1093\/eurheartj\/ehaa1040","article-title":"Genome-wide analysis identifies novel susceptibility loci for myocardial infarction.","volume":"4","author":"Pan","year":"2021","journal-title":"Eur Heart J"},{"key":"36","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1093\/ije\/dyq151","article-title":"Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants.","volume":"4","author":"Vanderweele","year":"2011","journal-title":"Int J Epidemiol"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.205061","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T11:49:51Z","timestamp":1697802591000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.205061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,2]]},"references-count":36,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2023,10,15]]}},"alternative-id":["205061","37787982"],"URL":"https:\/\/doi.org\/10.18632\/aging.205061","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,2]]}}}